Medicare drug price negotiation didn’t benefit Biden — but it may help Harris
WASHINGTON — When Vice President Kamala Harris takes the stage at the Democratic National Convention next week, she’ll have a fresh policy achievement to tout: The first round of Medicare-negotiated drug prices.
Harris’ introduction to Americans as the Democratic nominee for president is a second chance for Democrats to actually get credit for one of their biggest legislative accomplishments, the Inflation Reduction Act.
